Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients
NCT ID: NCT01686737
Last Updated: 2013-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-11-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is hypothesized that yoga is more effective than usual care and equally effective as aerobic exercise.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digitally Distributed Yoga for Women Treated for Breast Cancer
NCT04812652
Effects of Online Yoga on the Quality of Life of Breast Cancer Patients
NCT05327543
Yoga to Reduce Cancer Fatigue
NCT00583739
Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors
NCT00486525
Yoga Intervention for Reducing Fatigue in Cancer Patients
NCT04433793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Yoga
Iyengar Yoga
* 12 weeks of Iyengar yoga
* 2 weekly sessions of 60 minutes
Iyengar Yoga
* 12 weeks of Iyengar yoga
* 2 weekly sessions of 60 minutes
Aerobic exercise
Walking
* 12 weeks of walking
* 2 weekly sessions of 60 minutes
Walking
* 12 weeks of walking
* 2 weekly sessions of 60 minutes
Usual Care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iyengar Yoga
* 12 weeks of Iyengar yoga
* 2 weekly sessions of 60 minutes
Walking
* 12 weeks of walking
* 2 weekly sessions of 60 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* currently receiving adjuvant chemotherapy
* moderate to severe chemotherapy-induced fatigue
* physical and cognitive capacity to participate in yoga or walking
Exclusion Criteria
* ECOG status \> 1
* prior malignancy with a disease-free survival \< 10 years except curatively treated basalioma of the skin and carcinoma in situ of the cervix
* prior ductal carcinoma in situ (DCIS) ot the breast
* pregnancy or breastfeeding
* regular practice of yoga or walking during the past 12 months
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität Duisburg-Essen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Holger Cramer
Postdoctoral fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Holger Cramer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Duisburg-Essen, Chair of Complementary and Integrative Medicine
Gustav J. Dobos, MD
Role: STUDY_DIRECTOR
University of Duisburg-Essen, Chair of Complementary and Integrative Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brustzentrum Köln-Hohenlind, St. Elisabeth-Krankenhaus Köln-Hohenlind
Cologne, , Germany
Klinik für Senologie / Brustzentrum, Kliniken Essen-Mitte
Essen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.